CHRISTINE WERNER: Open Payments
NPI 1821700733 · MARIONVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,574 in 85 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,545 · 2025 $1,574
Food & beverage: $1,574
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $328 |
| Novo Nordisk Inc | 14 | $262 |
| Otsuka America Pharmaceutical, Inc. | 6 | $184 |
| ABBVIE INC. | 14 | $166 |
| PFIZER INC. | 9 | $150 |
| Lilly USA, LLC | 7 | $138 |
| Exact Sciences Corporation | 5 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $75 |
| Lundbeck LLC | 2 | $41 |
| Edwards Lifesciences Corporation | 1 | $38 |
Products named: BREZTRI, REXULTI, MOUNJARO, Wegovy, Ozempic, QULIPTA, UBRELVY, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
